Italian omeprazole triple therapy--a 1-week regimen.
Eradication of Helicobacter pylori infection is increasingly recognized as an appropriate therapeutic option, although it may prove difficult to achieve. Variable results, possibly due to side-effects, poor patient compliance and antimicrobial resistance, have been reported with traditional bismuth triple therapy. The combination of highly effective antisecretory drugs, such as omeprazole, and antimicrobial agents are providing a useful alternative to such traditional triple therapy.
Bazzoli
F
F
Dept. of Gastroenterology, University of Bologna, Italy.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000382:microbiology; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007558:Italy; D009853:Omeprazole / Q000627:therapeutic use*; D013997:Time Factors; D014011:Tinidazole / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D014011:Tinidazole; D017291:Clarithromycin; D009853:Omeprazole